Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1990
11/27/1990CA1276937C Leukotriene antagonists
11/27/1990CA1276936C Cardiotonic thiazolones
11/27/1990CA1276935C Triazolylcyclopropane antifungal agents
11/27/1990CA1276931C2 Process and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers
11/27/1990CA1276929C Cephalosporin antibacterial agents
11/27/1990CA1276898C Hypocholesterolemically and/or hypotriglyceridemically active rna fractions
11/27/1990CA1276897C Hypocholesterolemically active rna fractions
11/27/1990CA1276888C Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions
11/27/1990CA1276887C Anticariogenic or antiperiodontitic agent
11/27/1990CA1276882C Method for controlling bleeding
11/27/1990CA1276876C Anti-microbial systems containing the magnesium sulfate adduct of 2,2'-dithiobis pyridine 1,1'- dioxide and a water soluble zinc salt
11/26/1990WO1990014081A1 Onset-hastened/enhanced antipyretic response
11/26/1990WO1990014080A1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester
11/26/1990CA2067122A1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester
11/26/1990CA2017552A1 Amino-substituted heterocycles as renin inhibitors
11/26/1990CA2017542A1 Emulsified preparations containing perfluorocarbon compound
11/26/1990CA2017468A1 Aryloxyphenylpropylamines their preparation and use
11/26/1990CA2017446A1 Physiologically active material sn-198c production bacteria, novel physiologically active material sn-198c's and method for preparing same
11/26/1990CA2016141A1 8-substituted 4-(heterocyclylmethylamino) quinolines, the use thereof and drugs prepared therefrom
11/25/1990WO1990014343A1 Method for the preparation of active ingredients and pharmaceutical compositions for decorporating radioactive isotopes from living organisms
11/25/1990WO1990014007A1 Method for protection from azt side effects and toxicity
11/25/1990CA2057900A1 Method for protection from azt side effects and toxicity
11/25/1990CA2057878A1 9.alpha.-hydroxy-19,11.beta., bridged steroids, their production and pharmaceutical preparations containing these steroids
11/25/1990CA2033188A1 Method for the preparation of active ingredients and pharmaceutical compositions for decorporating radioactive isotopoes from living organisms
11/25/1990CA2017390A1 Compounds
11/25/1990CA2016574A1 Thiazepine derivatives
11/25/1990CA2014038A1 Intraocular pressure reducing 15-acyl prostaglandins
11/24/1990CA2017293A1 Compounds
11/24/1990CA2017248A1 7-aroyl-4-hydroxy-3-methyl-benzofurans as dual inhibitors of cyclooxygenase and 5-lipoxygenase
11/24/1990CA2016911A1 Hypoallergenic steroidal anesthetic/hypnotic compositions
11/23/1990WO1990014093A1 Water-soluble vitamin a preparations for application to the skin
11/23/1990CA2017310A1 Process for preparing 1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-o1
11/23/1990CA2017065A1 Heterocyclic compounds
11/22/1990EP0398789A1 Inhalant containing methoxamine
11/22/1990EP0398720A2 Piperazine derivatives
11/22/1990EP0398709A2 Genetic diagnosis of torsion dystonia
11/22/1990EP0398670A2 Process for 3-exomethylenecepham sulfoxide esters
11/22/1990EP0398631A1 Pharmaceutical composition
11/22/1990EP0398629A2 An oxadiazole and its salts, their use in treating dementia, their preparation and formulations
11/22/1990EP0398558A1 Isolation and structual elucidation of the cytostatic linear depsipeptide dolastatin 15
11/22/1990EP0398525A1 Compositions, containing inositol phosphate, preparation and uses
11/22/1990EP0398504A1 Thieno[3,4-d]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
11/22/1990EP0398484A2 Alpha-glycosyl-L-ascorbic acid, and its preparation and uses
11/22/1990EP0398460A2 Use of dihydrospirorenone as an anti-androgen
11/22/1990EP0398427A1 Antirhinoviral pyridazinamines
11/22/1990EP0398426A1 Antirhinoviral (thio)morpholinyl and piperazinyl alkylphenol ethers
11/22/1990EP0398425A1 Antirhinoviral piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers
11/22/1990EP0398413A1 "3,4-dehydropiperidine derivatives having psychotropic activity
11/22/1990EP0398367A2 Dimeric epipodophyllotoxin glucoside derivatives
11/22/1990EP0398336A1 Xanthocillin X monomethyl ether derivative and antitumor agent containing the same
11/22/1990EP0398326A2 Serotonin antagonist
11/22/1990EP0398313A2 Polysaccharides with an immunostimulating and antiproliferative activity, process for their recovery and medicines containing these substances
11/22/1990EP0398305A2 Anthracycline conjugates having a novel linker and methods for their production
11/22/1990EP0398288A2 Process for preparing optically active 2-arylalkanoic acids, in particular 2-arylpropionic acids
11/22/1990EP0398287A1 Pharmaceutical preparation
11/22/1990EP0398283A1 Excitatory amino acid antagonists
11/22/1990EP0398231A2 Nucleoside analogs
11/22/1990EP0398230A2 Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinoside monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
11/22/1990EP0398217A1 Dehydrocholecalciferol derivatives
11/22/1990EP0398207A1 Stable liquid form of 5-aminosalicylic acid
11/22/1990EP0398171A2 Use of imidazodiazepines in the treatment of neurological symptoms associated with circulatory disorders of the brain
11/22/1990EP0398165A1 Combination preparations containing rifampicin and thioacetazone and eventually isoniazide or ethambutol as active agents
11/22/1990EP0398142A1 New Benzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
11/22/1990EP0398033A1 Oral preparation
11/22/1990EP0398024A1 Conjugates for tumor localization and/or tumortherapy
11/22/1990EP0397914A1 Antitoxins for bacterial exotoxins
11/22/1990EP0397823A1 Contraception system and method
11/22/1990EP0397821A1 A novel family of high affinity, modified antibodies for cancer treatment
11/22/1990EP0397774A1 Formulation and use of retinoids in treatment of cancer and other diseases
11/22/1990EP0397689A1 Orthostatic lavage solutions.
11/22/1990EP0376959A4 Platinum pharmaceuticals
11/22/1990EP0190176B1 Use of doxaminol for the manufacture of a medicament for the treatment of peripheral artery occlusions
11/22/1990EP0166724B1 Composition for treating pediculosis
11/22/1990DE3916224A1 Compsns. for protecting retina in cataract operations - comprising UV absorber soln. applied to cornea
11/22/1990CA2017279A1 Process to prepare metastasis-inhibitory factor
11/22/1990CA2016836A1 Compounds
11/22/1990CA2014036A1 Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
11/21/1990CN1047083A Separating and purifying method for soy bean mixed phosphatide
11/21/1990CN1047081A Antimicrobial agents composition, process for preparing pyrrologuinoline derivatives using in same
11/21/1990CN1047080A Pyrimiding derivatives
11/21/1990CN1047078A Polyamines and polypetides useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
11/21/1990CN1047076A Phenethanolamine derivatives
11/20/1990WO1990014009A1 Therapeutic application of an anti-invasion compound
11/20/1990USRE33451 Artificial blood and other gas transport agents
11/20/1990US4971998 Menstruation, fenfluramine
11/20/1990US4971996 Hydroxystyrene compounds which are useful as tyrosine kinase inhibitors
11/20/1990US4971995 Inhibitors of monoamine oxidase, neurological disorders, aging, memory problems, schizophrenia, psydhaesthinia, parkinson*s disease
11/20/1990US4971992 Analgesics
11/20/1990US4971991 Physiological function enhancing agents activated by ultrasonic waves for the treatment of tumors
11/20/1990US4971986 Arylhydrazones useful as SAMDC inhibitors
11/20/1990US4971985 Pyridylketoxime ether compound and pharmaceutical composition containing it
11/20/1990US4971984 Cardiovascular disorders, hypotensive agints
11/20/1990US4971983 Use as anesthetics in surgery where a risk of cerebrovascular damage exists; e.g. riluzole
11/20/1990US4971982 Benzopyran derivatives
11/20/1990US4971980 Pharmacologically active benzimidazole derivatives
11/20/1990US4971979 Alkadiene derivatives, and pharmaceutical compositions containing them
11/20/1990US4971977 Anti-viral pharmaceutical compositions
11/20/1990US4971976 Anisodamine to prevent and treat eye disease
11/20/1990US4971975 Novel compounds
11/20/1990US4971974 Anorexigenic agents, benzo b!thieno 2,3-c!pyridine compounds
1 ... 7385 7386 7387 7388 7389 7390 7391 7392 7393 7394 7395 7396 7397 7398 7399 7400 7401 7402 7403 7404 7405 ... 7860